Investigational Site Number :8260002

Nottingham, Nottinghamshire NG5 1PB

0 studies enrolling now · 2 studies all time

What they study most

Alport Syndrome, Plasma Cell Myeloma

Studies at this site

• A Prospective, Non-interventional, Multinational, Observational Study With Isatuximab in Patients With Relapsed and/or Refractory Multiple Myeloma (RRMM) — Completed
• Study of Lademirsen (SAR339375) in Patients With Alport Syndrome — Stopped early